The Role of Cilostazol and Inflammation in Cognitive Impairment After Ischemic Stroke.
Ling-Chun HuangSun-Wung HsiehChia-Chan TsaiChun-Hung ChenYuan-Han YangPublished in: American journal of Alzheimer's disease and other dementias (2021)
Cilostazol did not make a significant difference in cognitive change after ischemic stroke. M1 macrophage subset increment may indicate post stroke cognitive decline. Due to limited number of subjects, these findings should be examined further in large-scale randomized clinical trials.